Novavax, Inc.
NVAX
$10.64
$0.565.56%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 121.63% | -66.84% | -34.41% | 451.51% | 54.58% |
| Total Depreciation and Amortization | -59.06% | -48.15% | -32.06% | -31.34% | 15.96% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 120.67% | 752.29% | -104.71% | 54.19% | -238.60% |
| Change in Net Operating Assets | -51.51% | 416.85% | -308.57% | -2,258.47% | 1.91% |
| Cash from Operations | 77.20% | 174.44% | -140.56% | -122.01% | 2.05% |
| Capital Expenditure | -7.45% | -47.01% | 91.41% | 82.26% | 78.14% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 148.30% | -504.13% | 130.11% | -19,281.45% | -19,441.42% |
| Cash from Investing | -85.78% | -527.83% | 129.81% | -911.30% | 1,686.33% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -127.65% | -92.19% | -67.21% | -511.39% | -18.84% |
| Issuance of Common Stock | -- | 1,174.22% | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 688.96% | -688.96% | -- |
| Cash from Financing | -92.99% | 43,854.64% | -100.40% | -219.96% | -103.41% |
| Foreign Exchange rate Adjustments | 84.05% | -89.08% | 5,167.95% | 68.53% | -467.40% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 36.93% | 113.44% | -104.76% | -203.63% | 47.55% |